Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

CEO Appointment

12 Jun 2014 07:00

RNS Number : 4176J
Wilmington Group Plc
12 June 2014
 



12 June 2014

Wilmington Group plc

 

("Wilmington" or "the Group")

 

Wilmington Group plc appoints Pedro Ros as Chief Executive

 

Wilmington Group plc today announces that Pedro Ros will join the Board of Wilmington on 14 July 2014 and will assume the role of Group Chief Executive on 1 October 2014 following the publication of the Group's preliminary 2014 results and completion of the associated investor roadshow. This follows the announcement of Charles Brady's retirement made on 25 February 2014.

 

Mr Ros (52) was, until June 2012, CEO and then Chairman of TNS, a global subsidiary of WPP plc, present in 80 countries and a world leader in market information and business analysis.

 

From January 2006 until the acquisition of TNS by WPP in October 2008, Mr Ros was executive director of Taylor Nelson Sofres plc, and Managing Director, TNS Global Clients & Sectors.

 

While working at TNS, Mr Ros undertook various roles, including Regional Director and Divisional Global Head; he contributed to a sustained period of organic growth, complemented by selective acquisitions which he successfully integrated into the enlarged group.

 

Mr Ros is Head of Strategic Insight at Creston plc, the digitally focused insight and communications group, a role which he will relinquish on 13 June 2014.

 

Mark Asplin, Chairman of Wilmington Group plc, said:

 

"The Board is delighted to welcome Pedro to Wilmington. His global experience combined with his proven ability to grow information and professional services businesses both organically and through successfully integrated acquisitions make him a natural choice for us. Pedro is taking on a strong platform at Wilmington which is well positioned for the next phase of its evolution."

 

Pedro Ros said:

 

"Wilmington has leading market positions in its increasingly global core markets. An ongoing focus on developing a high value offer, a leading digital strategy and an ambitious international growth agenda will allow us to deliver value for both our customers and our shareholders, capitalising on our current and future opportunities".

 

Pedro Ros has confirmed that, save as set out in this announcement, there are no further disclosures to be made under Listing Rule 9.6.13.

 

-End-

 

For further information, please contact:

 

Wilmington Group Plc

Mark Asplin, Chairman

 

FTI Consulting

Charles Palmer 

020 7422 6800

 

 

020 3727 1000

 

Notes to Editors

 

Wilmington Group plc is one of the UK's leading providers of Information, Compliance and Education for professional business markets. The Group provides business intelligence, information, training, education, events and support services for a variety of markets including the accountancy, banking, charities, financial services, healthcare, insurance, legal, and pensions sectors. Capitalised at approximately £170 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAQFLFFZQFXBBB
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.